Is Cresco Labs Inc. (CL.CN) a Buy, Sell, or Hold?
CNQ : CL.CN
Cresco Labs Inc.
$1 CAD
-$0.01 (-0.99%)
- Volume
- 38.01K
- Average Volume
- 188.61K
- Market Capitalization
- $354.23M
- P/E Ratio
- -1.78
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.12
- Year Low
- $0.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.51
Company Overview
CNQ
Charles Bachtell
Drug Manufacturers - Specialty & Generic
Healthcare
CL.CN
2900
US
CAD
Liquidity Metrics
1.75
2.51
1.41
0.65
0.00
Sales & Valuation
$667.33M
0.39
0.77
-1147.08
0.00
Profitability
-$0.42
-$137.78M
-21.28%
-15.36%
-35.26%
-11.36%
P/E Metrics
-1.78
0.01
0.01
Analyst Price Target & Rating
2/5
6 Analysts
%
Financial Health Scores
-0.76
2/9
$148.6M
$1.2B
$955.32M
$62.79M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Angie Demchenko | Chief People Officer |
| Cole | Senior Vice President of Corporate Development and Investor Relations |
| Gregory Butler | President |
| Joseph Ales | Senior Vice President of Operations |
| Sharon Schuler | Chief Financial Officer |
| Charles Bachtell | Co-Founder, Chief Executive Officer & Director |
| Robert Sampson | Co-Founder & Independent Director |
| Zach Marburger | Chief Information Officer |
| John Schetz | General Counsel |
| Ty Gent | Chief Operating Officer |
Poll Results
No votes yet today — be the first to share your view!
About Cresco Labs Inc. (CNQ:CL.CN) Stock
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL. ...
Frequently Asked Questions
-
What is the current Cresco Labs Inc. (CL.CN) stock price?
-
Cresco Labs Inc.(CNQ:CL.CN) stock price is $1 in the last trading session. During the trading session, CL.CN stock reached the peak price of $3.12 while $0.78 was the lowest point it dropped to. The percentage change in CL.CN stock occurred in the recent session was --0.99% while the dollar amount for the price change in CL.CN stock was -$0.01.
-
CL.CN's industry and sector of operation?
-
The CNQ listed CL.CN is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of CL.CN?
-
Angie Demchenko | Chief People Officer
Cole | Senior Vice President of Corporate Development and Investor Relations
Gregory Butler | President
Joseph Ales | Senior Vice President of Operations
Sharon Schuler | Chief Financial Officer -
How many employees does CL.CN have?
-
Number of CL.CN employees currently stands at 2900. CL.CN operates from 600 W. Fulton Street, Chicago, IL 60661, US.
-
Link for CL.CN official website?
-
Official Website of CL.CN is: https://www.crescolabs.com
-
How do I contact CL.CN?
-
CL.CN could be contacted at phone #312 929 0993 and can also be accessed through its website. CL.CN operates from 600 W. Fulton Street, Chicago, IL 60661, US.
-
How many shares of CL.CN are traded daily?
-
The average number of CL.CN shares traded daily for last 3 months was 188.61K.
-
What is the market cap of CL.CN currently?
-
The market value of CL.CN currently stands at $354.23M with its latest stock price at $1